BeiGene (BGNE) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period BeiGene (NASDAQ:BGNE) Earns Hold Rating from Analysts at StockNews.comJanuary 19 at 2:05 AM | americanbankingnews.comBeiGene Schedules EGM for Strategic Corporate ChangesJanuary 17, 2025 | tipranks.comBeiGene Projects Positive Operating Income by 2025January 13, 2025 | tipranks.comBeiGene (NASDAQ:BGNE) Now Covered by StockNews.comJanuary 12, 2025 | americanbankingnews.comBeigene-Direktor Wang Xiaodong veräußert Aktien im Wert von 7,37 Millionen US-DollarJanuary 9, 2025 | de.investing.comBeiGene, Ltd.: TEVIMBRA erhält US-Marktzulassung für die Erstlinienbehandlung von Magen- und GEJ-Tumoren in Kombination mit ChemotherapieDecember 30, 2024 | finanznachrichten.deBeiGene Announces FDA Approval Of TEVIMBRA - Quick FactsDecember 27, 2024 | markets.businessinsider.comBeiGene Secures FDA Approval for Stomach Cancer DrugDecember 27, 2024 | msn.comBeiGene announces FDA approval of TevimbraDecember 27, 2024 | markets.businessinsider.comBeiGene wins FDA nod for Tevimbra in gastric cancerDecember 27, 2024 | msn.comTEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with ChemotherapyDecember 27, 2024 | businesswire.comBeiGene, Ltd. (NASDAQ:BGNE) Receives Average Recommendation of "Moderate Buy" from AnalystsBeiGene, Ltd. (NASDAQ:BGNE - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight research firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy rDecember 25, 2024 | marketbeat.comWith 45% institutional ownership, BeiGene, Ltd. (NASDAQ:BGNE) is a favorite amongst the big gunsDecember 24, 2024 | finance.yahoo.comBeiGene to Change Nasdaq Ticker Symbol to "ONC" on January 2; Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | uk.finance.yahoo.comBeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | businesswire.comBeiGene-Aktien erhalten erneut Kaufempfehlung aufgrund robuster Onkologie-PipelineDecember 18, 2024 | de.investing.comBeiGene’s Strategic Advancements and Promising Clinical Developments Justify Buy RatingDecember 18, 2024 | markets.businessinsider.comBeiGene (BGNE) Gets a Buy from TD CowenDecember 18, 2024 | markets.businessinsider.comStifel Financial Corp Sells 4,366 Shares of BeiGene, Ltd. (NASDAQ:BGNE)Stifel Financial Corp lessened its stake in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 25.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,807 shares of the company's stock after sellingDecember 18, 2024 | marketbeat.comBeiGene: Promising Growth Trajectory and Investment Opportunity Backed by Strong Product Pipeline and Robust FinancialsDecember 17, 2024 | markets.businessinsider.comPublic Employees Retirement System of Ohio Reduces Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)Public Employees Retirement System of Ohio reduced its position in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 73.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,917 shares of the company's stoDecember 17, 2024 | marketbeat.comBeiGene, Ltd. (NASDAQ:BGNE) Sees Significant Increase in Short InterestBeiGene, Ltd. (NASDAQ:BGNE - Get Free Report) saw a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 1,330,000 shares, a growth of 33.1% from the November 15th total of 999,400 shares. Based on an average daily volume of 367,900 shares, the short-interest ratio is presently 3.6 days.December 14, 2024 | marketbeat.comInsider Selling: BeiGene, Ltd. (NASDAQ:BGNE) Insider Sells 41,760 Shares of StockDecember 13, 2024 | insidertrades.comBeiGene Announces Global Licensing Agreement for MAT2A InhibitorDecember 12, 2024 | businesswire.comTracking Baker Brothers Portfolio - Q3 2024 UpdateDecember 12, 2024 | seekingalpha.comBeiGene’s Strong Pipeline and Financial Position Make It a Compelling Buy OpportunityDecember 12, 2024 | markets.businessinsider.comBeiGene-Präsident Wu Xiaobin meldet Verkauf wirtschaftlicher Beteiligung im Wert von 120.894 US-DollarDecember 11, 2024 | de.investing.comBros. Advisors Lp Baker Sells 1,037,017 Shares of BeiGene, Ltd. (NASDAQ:BGNE) StockDecember 11, 2024 | insidertrades.comBeiGene’s Promising CLL Market Potential: Buy Rating Driven by Strong BTK Degrader Data and Competitive EdgeDecember 11, 2024 | markets.businessinsider.comBeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline AssetsDecember 9, 2024 | businesswire.comXTX Topco Ltd Takes Position in BeiGene, Ltd. (NASDAQ:BGNE)XTX Topco Ltd bought a new position in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 7,191 shares of the company's stock, valued at approximately $1,614,000. SeDecember 9, 2024 | marketbeat.comMorgan Stanley Reaffirms Their Buy Rating on BeiGene (BGNE)December 6, 2024 | markets.businessinsider.comTemasek Holdings Private Ltd Has $536.26 Million Stock Holdings in BeiGene, Ltd. (NASDAQ:BGNE)Temasek Holdings Private Ltd trimmed its stake in BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 20.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,388,576 shares of the company's stock after selling 625,595 sharesDecember 6, 2024 | marketbeat.comHillhouse Investment verkauft Beigene-Aktien im Wert von 3,57 Milliarden US-DollarDecember 4, 2024 | de.investing.comBeiGene assumed with an Overweight at Morgan StanleyDecember 4, 2024 | markets.businessinsider.comBeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLLDecember 4, 2024 | finance.yahoo.comA Glimpse Into The Expert Outlook On BeiGene Through 4 AnalystsDecember 4, 2024 | benzinga.comBeiGene and CLL Society Partner to Advance Test Before Treatâ„¢ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLLDecember 4, 2024 | businesswire.comErste Asset Management GmbH Invests $4.48 Million in BeiGene, Ltd. (NASDAQ:BGNE)Erste Asset Management GmbH bought a new stake in BeiGene, Ltd. (NASDAQ:BGNE - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 20,500 shares of the company's stock, valued at approximately $4,478,000. Several other hedge funds and other iDecember 3, 2024 | marketbeat.comBeiGene, Ltd. (NASDAQ:BGNE) Shares Acquired by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company grew its position in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 14.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,384 shares of theDecember 3, 2024 | marketbeat.comBiotech Stocks Facing FDA Decision In December 2024December 2, 2024 | markets.businessinsider.comBeiGene to Host Investor Webcast Highlighting Key Data from ASH and the San Antonio Breast Cancer Symposium on December 16, 2024December 2, 2024 | businesswire.comCitigroup Inc. Buys 5,410 Shares of BeiGene, Ltd. (NASDAQ:BGNE)Citigroup Inc. increased its stake in BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 25.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,312 shares of the company's stock after acquiring an additional 5,410December 2, 2024 | marketbeat.comBeiGene: Nearing Profitability On TEVIMBRA Approval In The EU And USDecember 1, 2024 | seekingalpha.comBellevue Group AG Increases Position in BeiGene, Ltd. (NASDAQ:BGNE)Bellevue Group AG lifted its position in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 129.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 58,729 shares of the company's stock after purchasing an addiDecember 1, 2024 | marketbeat.comWalleye Capital LLC Has $6 Million Stake in BeiGene, Ltd. (NASDAQ:BGNE)Walleye Capital LLC raised its stake in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 50.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 26,721 shares of the company's stock after buying an additional 8,924 shares dDecember 1, 2024 | marketbeat.comBeiGene, Ltd. (NASDAQ:BGNE) Shares Acquired by Fmr LLCFmr LLC lifted its holdings in BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 0.8% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,660,011 shares of the company's stock after purchasing an additional 12,855 shares during the period. FmrDecember 1, 2024 | marketbeat.comBeiGene, Ltd. (NASDAQ:BGNE) Insider Xiaodong Wang Sells 40,468 SharesNovember 30, 2024 | insidertrades.comBeiGene, Ltd. (NASDAQ:BGNE) Given Average Recommendation of "Moderate Buy" by AnalystsShares of BeiGene, Ltd. (NASDAQ:BGNE - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buyNovember 30, 2024 | marketbeat.comBeiGene, Ltd. (NASDAQ:BGNE) Insider Sells $7,692,966.80 in StockBeiGene, Ltd. (NASDAQ:BGNE - Get Free Report) insider Xiaodong Wang sold 40,468 shares of the firm's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $190.10, for a total value of $7,692,966.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.November 29, 2024 | marketbeat.com Get BeiGene News Delivered to You Automatically Sign up to receive the latest news and ratings for BGNE and its competitors with MarketBeat's FREE daily newsletter. Email Address BGNE Media Mentions By Week BGNE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BGNE News Sentiment▼0.000.60▲Average Medical News Sentiment BGNE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BGNE Articles This Week▼26▲BGNE Articles Average Week Get BeiGene News Delivered to You Automatically Sign up to receive the latest news and ratings for BGNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today TAK News Today ARGX News Today BNTX News Today TEVA News Today SMMT News Today GMAB News Today VTRS News Today ITCI News Today MRNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BGNE) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeiGene, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeiGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
